Synopsys (NASDAQ:SNPS) Price Target Raised to $450.00 at BNP Paribas Exane

Synopsys (NASDAQ:SNPS) had its price target increased by investment analysts at BNP Paribas Exane from $425.00 to $450.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “underperform” rating on the semiconductor company’s stock. BNP Paribas Exane’s target price would suggest a potential downside of 6.08% from the stock’s previous close.

SNPS has been the subject of a number of other research reports. Rosenblatt Securities lifted their price target on Synopsys from $530.00 to $575.00 and gave the stock a “buy” rating in a report on Tuesday. Stifel Nicolaus lifted their price target on Synopsys from $550.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the stock a “buy” rating in a report on Wednesday, February 25th. Bank of America boosted their price objective on Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday. Finally, Citigroup boosted their price objective on Synopsys from $580.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Nine analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $563.19.

Synopsys Stock Down 8.9%

Shares of NASDAQ:SNPS traded down $46.78 during midday trading on Thursday, reaching $479.14. The company had a trading volume of 2,771,818 shares, compared to its average volume of 2,007,367. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The business’s 50 day moving average price is $457.56 and its 200 day moving average price is $453.69. The stock has a market cap of $91.79 billion, a PE ratio of 74.55, a P/E/G ratio of 4.38 and a beta of 1.25. Synopsys has a 1-year low of $376.18 and a 1-year high of $651.73.

Synopsys (NASDAQ:SNPS) last released its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.Synopsys’s quarterly revenue was up 41.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Research analysts forecast that Synopsys will post 10.28 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Sowell Financial Services LLC increased its holdings in Synopsys by 2.0% in the fourth quarter. Sowell Financial Services LLC now owns 1,056 shares of the semiconductor company’s stock valued at $496,000 after purchasing an additional 21 shares during the period. Natural Investments LLC increased its holdings in Synopsys by 4.6% in the fourth quarter. Natural Investments LLC now owns 482 shares of the semiconductor company’s stock valued at $226,000 after purchasing an additional 21 shares during the period. Financial Management Professionals Inc. increased its holdings in Synopsys by 7.0% in the fourth quarter. Financial Management Professionals Inc. now owns 335 shares of the semiconductor company’s stock valued at $157,000 after purchasing an additional 22 shares during the period. Foronjy Financial LLC increased its holdings in Synopsys by 5.2% in the fourth quarter. Foronjy Financial LLC now owns 446 shares of the semiconductor company’s stock valued at $210,000 after purchasing an additional 22 shares during the period. Finally, Barden Capital Management Inc. increased its holdings in Synopsys by 1.2% in the fourth quarter. Barden Capital Management Inc. now owns 1,868 shares of the semiconductor company’s stock valued at $877,000 after purchasing an additional 23 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.

More Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys reported fiscal Q2 results that topped Wall Street expectations, with adjusted EPS of $3.35 versus $3.15 expected and revenue of $2.28 billion, up 41.9% year over year. Synopsys Posts Financial Results for Second Quarter Fiscal Year 2026
• Positive Sentiment: The company raised full-year guidance, pointing to continued demand for AI-related chip design software and stronger operating margins, which supports the longer-term earnings outlook. Synopsys raises annual forecast on demand for AI chip design software
• Positive Sentiment: Synopsys also announced a governance agreement with Elliott Investment Management, adding Jesse Cohn to the board, which could improve capital allocation and margin discipline. Synopsys reaches settlement with Elliott, says Jesse Cohn to join board
• Positive Sentiment: Synopsys highlighted new AI-powered design flows and certified IP for Samsung Foundry’s latest 2nm processes, reinforcing its position in advanced chip design and AI infrastructure. Synopsys Advances Power and Performance for AI and Multi-Die Designs on Latest Samsung Foundry Processes at SAFE Forum 2026
• Neutral Sentiment: Several analysts reiterated or raised price targets after the report, signaling continued confidence, but not enough to offset the day’s caution. Analyst rating updates on Synopsys
• Negative Sentiment: Despite the beat-and-raise results, shares fell as investors worried about weakness in the chip IP business and the market’s focus shifted to integration and margin questions around the Ansys deal. Synopsys Stock Falls After Earnings Beat With AI and Merger in Focus

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.